LINC02057

Across TCGA pan-cancer cohorts, LINC02057 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC02057’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02057 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02057 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.

COAD, READ, and UCEC are the cancer types where LINC02057 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02057 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−2.316	<.001	11	view →
READ	All	II,III,IV	−1.645	<.001	6	view →
UCEC	All	All	−0.683	.006	4	view →
BLCA	Male	IV	−0.175	.013	3	view →
PRAD	All	All	−0.289	<.001	2	view →
ESCA	Male	All	−0.454	.017	1	view →
LIHC	Male	All	−0.036	.002	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC02057–COAD

Open the COAD breakdown →